Replies to post #111514 on Avid Bioservices Inc (CDMO)

[geocappy1]

"We are pleased with the results seen in this very difficult to treat patient population," said Kerstin Menander, MD, PhD, head of medical oncology at Peregrine. "Although the median overall survival improvement is modest, further analysis of the data including subgroups shows some very interesting and potentially promising trends. We look forward to presenting the full data set from this trial later this year at an upcoming scientific meeting."

[corporalagarn]

Is there any chance this upcoming medical conference will conflict with the upcoming HCV medical conference from 2012? I'd like to attend both if possible.

[patientlywaiting]

My question, if this PR announcement was "Event Driven" it seems they could have let us know sometime ago. Did the last patient die yesterday? Again, left with more questions then answers!

IMHO